| ID | 10380 |
| Vaccine Name | Trivalent combination vaccine |
| Disease Name | Norovirus Infection |
| Disease Classification | Gastrointestinal |
| Virus Name | Norovirus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Virus like particle |
| Vaccine Status | Preclinical |
| Manufacturer | University of Tampere |
| Year of Manufacturing | 2013 |
| Manufacturing Country | Finland |
| Age | NA |
| Dosage | NA |
| Administration Route | Intramuscular, Intranasal |
| Adjuvant | NA |
| Target Strain | GII-4, GI-3 VLP, rVP6 |
| Description | Baculovirus expressed noroviruses VLPs |
| Approving Organisation | NA |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | NA |
| PMID | 23922988 |
| Clinical Trial ID | NA |
| Reference Link | https://www.cdc.gov/norovirus/downloads/global-burden-report.pdf |
| Additional Links | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724941/
|